[COVID-19 vaccination in patients suffering from respiratory diseases. Update of 25th June 2021]

E Blanchard; A Ozier; C Janssen; B Wyplosz; C Andrejak

doi:10.1016/j.rmr.2021.07.003

[COVID-19 vaccination in patients suffering from respiratory diseases. Update of 25th June 2021]

Rev Mal Respir. 2021 Sep;38(7):780-793. doi: 10.1016/j.rmr.2021.07.003. Epub 2021 Aug 3.

[Article in French]

Authors

E Blanchard¹, A Ozier², C Janssen³, B Wyplosz⁴, C Andrejak⁵

Affiliations

¹ Service de pneumologie CHU Bordeaux, 1, avenue de Magellan, 33604 Pessac cedex, France. Electronic address: elodie.blanchard@chu-bordeaux.fr.
² Cabinet de pneumologie, Clinique Saint-Augustin, Bordeaux, France.
³ Service des maladies infectieuses et tropicales, CH Annecy-Genevois, Annecy, France.
⁴ Service des maladies infectieuses et tropicales, Hôpital Kremlin-Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.
⁵ Service de pneumologie, CHU Amiens, Amiens, France.

No abstract available

Keywords: COVID-19; Cancer bronchique; Immunosuppresseur; Immunosuppressive agent; Lung cancer; Maladies respiratoires; Respiratory disease; Vaccination.

Publication types

Practice Guideline

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
Respiration Disorders* / epidemiology
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines